Ischemic stroke. Stroke, not specified as haemorrhage or infarction
Conditions
Interventions
Intervention 1: Intervention group: Two packages each contains 30 gr trehalose in the first 24 hours, then one package (30 gr) daily till 5 days (or until discharge in case of discharge earlier than 5
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with ischemic stroke Age more than 18 years old Satisfaction for participation in research project (by the patient or his guardian). NISS score between 5-25 or less than 5 with aphasia, ataxia, or anopia.
Exclusion criteria
Exclusion criteria: Willingness to withdraw from the study Pregnancy or breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| C-reactive protein (CRP). Timepoint: Baseline and after 5 days (or at the time of discharge in case of discharge earlier than 5 days). Method of measurement: Blood test.;Modified Rankin Scale (MRS). Timepoint: Baseline and after 5 days (or at the time of discharge in case of discharge earlier than 5 days), after 1 and 3 months of intervention. Method of measurement: Checklist.;Complete Blood Count (CBC). Timepoint: Baseline and after 5 days (or at the time of discharge in case of discharge earlier than 5 days). Method of measurement: Blood test.;National Institutes of Health Stroke Scale (NIHSS). Timepoint: Baseline and after 5 days (or at the time of discharge in case of discharge earlier than 5 days). Method of measurement: Checklist and physical examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of stroke complication such as recurrent stroke, myocardial infarction (MI), transient ischemic attack (TIA), bleeding, mortality. Timepoint: Monthly for 3 months. Method of measurement: By asking questions from the patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohsen Soltani
Mashhad University of Medical Sciences
Outcome results
None listed